Patisiran’s path to approval as an RNA therapy

Nature, Published online: 16 October 2019; doi:10.1038/d41586-019-03070-wCarlos Heras-Palou explains his part in making the first RNA-interference therapeutic available to people with rare diseases.

Source: Nature AOP - October 15, 2019 Category: Research Authors: Carlos Heras-Palou Source Type: research